The Morning News http://ift.tt/2xJsiUU
It’s unclear whether drugmakers are purposely ignoring what they know of Omics’s reputation or are genuinely confused amid the profusion of noncredible journals—none were willing to discuss their involvement in any depth.
↩︎ Bloomberg
No comments:
Post a Comment